Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Intratumoral and Peritumoral Features for Predicting Microvascular Invasion in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.

Created on 27 Sep 2026

Authors

Benqi Zhao, Yibei Yu, Yuling Yang, Lixue Wang, Jie Li

Published in

Journal of visualized experiments : JoVE. Issue 235. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

This systematic review and meta-analysis evaluated the diagnostic performance of radiomics-based models for predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC). MVI is a key determinant of prognosis in HCC, strongly associated with early recurrence and reduced survival following curative treatment. Accurate preoperative prediction of MVI remains challenging using conventional clinical and imaging features. Radiomics has emerged as a promising approach by enabling quantitative analysis of tumor heterogeneity from medical imaging. This study aimed to systematically evaluate the diagnostic performance of radiomics-based models for predicting MVI in HCC. A systematic review and meta-analysis were conducted, including 26 studies evaluating CT- and MRI-based radiomics models. Data on diagnostic performance were extracted, and pooled analyses were performed using random-effects models, with subgroup analyses by imaging modality and model type. Overall, radiomics models demonstrated good diagnostic performance, with a pooled AUC of 0.85 (95% CI 0.82-0.88). Clinicoradiomics models achieved higher and more consistent performance than radiomics-only models (MRI: 0.87 vs 0.85; CT: 0.87 vs 0.81). Among 3D-based models, the pooled AUC was 0.85 (95% CI 0.82-0.88). In conclusion, radiomics-based models show promising performance for preoperative prediction of MVI in HCC, particularly when combined with clinical variables. However, considerable heterogeneity and limited external validation highlight the need for methodological standardization and prospective multicenter validation before clinical implementation.

PMID:
42801297
Bibliographic data and abstract were imported from PubMed on 27 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement